Trademark: 77501680
Status Date
Monday, February 20, 2012
Filing Date
Wednesday, June 18, 2008
Published for Opposition
Tuesday, October 28, 2008
Abandoned Date
Monday, February 20, 2012
5 Pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, central nervous system diseases and disorders, and infectious-related diseases and disorders
The mark has no meaning in a foreign language.
Feb 21, 2012
Abandonment Notice Mailed - No Use Statement Filed
Feb 20, 2012
Abandonment - No Use Statement Filed
Jul 23, 2011
Notice Of Approval Of Extension Request Mailed
Jul 22, 2011
Extension 5 Granted
Jul 18, 2011
Extension 5 Filed
Jul 18, 2011
Teas Extension Received
Jan 21, 2011
Notice Of Approval Of Extension Request Mailed
Jan 20, 2011
Extension 4 Granted
Jan 17, 2011
Extension 4 Filed
Jan 17, 2011
Teas Extension Received
Jul 24, 2010
Notice Of Approval Of Extension Request Mailed
Jul 23, 2010
Extension 3 Granted
Jul 19, 2010
Extension 3 Filed
Jul 19, 2010
Teas Extension Received
Jan 29, 2010
Extension 2 Granted
Jan 18, 2010
Extension 2 Filed
Jan 18, 2010
Teas Extension Received
Aug 19, 2009
Extension 1 Granted
Jul 20, 2009
Extension 1 Filed
Aug 19, 2009
Case Assigned To Intent To Use Paralegal
Jul 20, 2009
Teas Extension Received
Jan 20, 2009
Noa Mailed - Sou Required From Applicant
Oct 28, 2008
Published For Opposition
Oct 8, 2008
Notice Of Publication
Sep 24, 2008
Law Office Publication Review Completed
Sep 24, 2008
Assigned To Lie
Sep 15, 2008
Approved For Pub - Principal Register
Sep 14, 2008
Assigned To Examiner
Jun 23, 2008
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
